The global market for respiratory and non-respiratory IVD panel-based testing is undergoing continued structural evolution. Panel-based tests allow for the simultaneous detection of multiple pathogens and or resistance markers from a single specimen, supporting efficient workflows, faster time to results, and greater diagnostic confidence. Market growth is increasingly driven by broader clinical adoption and expanding use across a range of testing environments.

Kalorama Information analyzes, estimates, and forecasts this market in Worldwide IVD Panel-Based Testing: Respiratory/Non-Respiratory, 2020-2030.

Segment Landscape

Respiratory panels remain an important component of the panel-based testing market, supported by widespread clinical use and recurring seasonal demand. These tests are offered across multiple formats, including molecular, immunoassay, and point-of-care platforms, and represent a meaningful share of overall market revenues.

Non-respiratory panels account for a growing portion of panel-based testing and span a range of applications, including infectious disease and other specialized testing areas. This segment reflects increasing test menu diversity and the integration of panel-based approaches across multiple laboratory settings.

End Users and Care Settings

Demand for panel-based testing is concentrated in hospital and acute care environments, where broad test menus and rapid clinical decision-making are essential. Emergency and urgent care settings contribute significant testing volumes, while additional utilization occurs across other care settings for non-respiratory applications.

Geographic Scope

North America is the largest regional market for respiratory and non-respiratory IVD panel-based testing, supported by a well-established installed base and mature diagnostic infrastructure. Worldwide IVD Panel-Based Testing: Respiratory/Non-Respiratory, 2020-2030 also examines Europe, Asia Pacific, and the Rest of the World to provide a global market perspective.

Scope and Methodology

This report analyzes the global IVD panel-based testing market at the manufacturer level, covering both respiratory and non-respiratory tests across multiple technology categories:

• Molecular
• Immunoassay
• Point-of-care
• Core laboratory
• Anatomic pathology
• Immunohematology

Market data spans 2020 through 2030, with 2025 as the base year and CAGR calculations provided for the 2025 to 2030 forecast period. Regional and end-user analyses are included, with forecasts informed by demographic trends, technological innovation, new product development, and global expansion.

Research findings are based on extensive primary and secondary research, including interviews with industry executives, consultants, healthcare providers, and government personnel, supported by analysis of company materials, databases, investment reports, and medical and business journals.